A low frequency of lymph node metastasis in clear-cell renal cell carcinoma is related to low lymphangiogenic activity

BJU International

Volumn 103, Issue 12, 2009, Pages 1626-1631

  Baldewijns, Marcella M ^a,e   Roskams, Tania ^b   Ballet, Vera ^a   Van Den Eynden, Gert G ^c,d   Van Laere, Steven J ^c,d   Van Der Auwera, Ilse ^c,d   Lerut, Evelyne ^b   De Bruïne, Adriaan P ^a   Thijssen, Victor L ^a   Vermeulen, Peter B ^c,d   Van Poppel, Hein ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d SINT AUGUSTINUS HOSPITAL   (Belgium)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Lymphangiogenesis; Podoplanin; Prox 1; Renal carcinoma; VEGF

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY D2-40; VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LYMPH NODES; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; VASCULAR ENDOTHELIAL GROWTH FACTORS; YOUNG ADULT;

EID: 67149097789     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08272.x     Document Type: Article

References (30)

1. Bonsib SM. The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas. Am J Surg Pathol 2004 28 : 1594 600
2. Minervini A, Lilas L, Morelli G et al. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery? BJU Int 2001 88 : 169 72
3. Terrone C, Cracco C, Porpiglia F et al. Reassessing the current TNM lymph node staging for renal cell carcinoma. Eur Urol 2006 49 : 324 31
4. Stacker SA, Caesar C, Baldwin ME et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001 7 : 186 91
5. Skobe M, Hawighorst T, Jackson DG et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001 7 : 192 8
6. Padera TP, Kadambi A, di Tomaso E et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002 296 : 1883 6
7. Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii S. VEGFR-3 and CD133 identify a population of CD34+ lymphatic-vascular endothelial precursor cells. Blood 2003 101 : 168 72
8. He Y, Rajantie I, Ilmonen M et al. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 2004 64 : 3737 40
9. Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev 2002 82 : 673 700 (Pubitemid 34743335)
10. Nagy JA, Vasile E, Feng D et al. Vascular permeability factor-vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002 196 (11 1497 506
11. Cursiefen C, Chen L, Borges LP et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004 113 : 1040 50
12. Partanen TA, Makinen T, Arola J et al. Endothelial growth factor receptors in human fetal heart. Circulation 1999 100 : 583 6
13. Cao R, Bjorndahl MA, Religa P et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 2004 6 : 333 45
14. Hong YK, Detmar M. Prox1, master regulator of the lymphatic vasculature phenotype. Cell Tissue Res 2003 314 : 85 92 (Pubitemid 37409915)
15. Van der Auwera I, Cao Y, Tille JC et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 2006 95 : 1611 25
16. Van der Auwera I, Van den Eynden GG, Colpaert CG et al. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clin Cancer Res 2005 11 : 7637 42
17. Ishikawa Y, Aida S, Tamai S et al. Significance of lymphatic invasion and proliferation on regional lymph node metastasis in renal cell carcinoma. Am J Clin Pathol 2007 128 : 198 207 (Pubitemid 47262617)
18. Horiguchi A, Ito K, Sumitomo M et al. Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma. Urology 2008 71 : 928 32
19. Iwata T, Miyata Y, Kanda S et al. Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry. Urology 2008 71 : 749 54
20. Tomisawa M, Tokunaga T, Oshika Y et al. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. Eur J Cancer 1999 35 : 133 7
21. Baldewijns MM, Thijssen VL, Van den Eynden GG et al. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. Br J Cancer 2007 96 : 1888 95
22. Fox SB, Leek RD, Weekes MP et al. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995 177 : 275 83
23. Thijssen VL, Brandwijk RJ, Dings RP, Griffioen AW. Angiogenesis gene expression profiling in xenograft models to study cellular interactions. Exp Cell Res 2004 299 : 286 93
24. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T) method. Methods 2001 25 : 402 8
25. Padera TP, Stoll BR, Tooredman JB et al. Pathology: cancer cells compress intratumour vessels. Nature 2004 427 : 695 (Pubitemid 38294577)
26. Bonsib SM. Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases. Mod Pathol 2006 19 : 746 53
27. Turner KJ, Moore JW, Jones A et al. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 2002 62 : 2957 61
28. Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005 5 : 735 43
29. Stuht S, Gwinner W, Franz I et al. Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies. Am J Transplant 2007 7 : 377 84
30. Maruyama K, Ii M, Cursiefen C et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 2005 115 : 2363 72